Bristol Meyers

Discussion in 'Technical Analysis' started by ZZZzzzzzzz, Oct 20, 2005.

  1. BMY
     
    • bmy.gif
      File size:
      8.1 KB
      Views:
      166
  2. Surdo

    Surdo

    The company pays a $1.12 Dividend, which at these levels is over 5%. Below $20 makes BMY ripe for a takeover.
     
  3. BMY
     
    • bmy.png
      File size:
      15.2 KB
      Views:
      95
  4. Deptrai

    Deptrai

    Why not PFE?
     
  5. dealmaker

    dealmaker

    BMS Buys Celgene

    In one of the biggest pharma takeovers ever, Bristol-Myers Squibb is paying $90 billion for Celgene, a company specializing in leukemia treatment. BMS thus far has a focus on solid tumors. Celgene CEO Mark Alles said the two companies had "complementary assets in different diseases and here we get to build on the scientific capabilities of both in a way that could not happen without this deal." Wall Street Journal
     
  6. dealmaker

    dealmaker

    On Thursday, 01/04/19, Celgene (CELG) appreciated 20.7% after agreeing to be acquired by Bristol-Myers Squibb (BMY).
     
  7. dealmaker

    dealmaker

    WSJ got BMY ticker symbol wrong...